Subscribe to Diagnostics
View Sample

FREE Email Newsletter

Hologic's 3D Mammography Technology to be the "New Standard of Care," According to Healthcare Research Firm KLAS

March 19, 2013 5:27 pm | by PR Newswire | News | Comments

BEDFORD, Mass., March 19, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced...

Douglas Harrington, MD Addresses Select Group of Physicians Regarding Latest Advances in Cardiovascular Risk Assessment

March 19, 2013 2:44 pm | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Mar 19, 2013--Aviir Inc., a biotechnology company dedicated to enhanced detection and prevention of cardiovascular disease through innovative diagnostic tests, announced that Douglas Harrington, MD, Clinical Professor of Pathology at USC and Aviir, Inc. CEO,...

DiaTech Oncology Test Shows Improved Results, New Hope for Leukemia Patients

March 19, 2013 8:37 am | by The Associated Press | News | Comments

NASHVILLE, Tenn.--(BUSINESS WIRE)--Mar 19, 2013--Results of clinical trials published this month in the medical peer-review journal showed overall survival rate improved 257% for certain groups of leukemia patients when physicians used DiaTech Oncology’s test to help determine chemotherapy...


Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders

March 18, 2013 1:07 pm | by Bio-Medicine.Org | News | Comments

Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available...

Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and Quantstudio(TM) DX and 7500 Fast DX Real-Time PCR Instruments

March 18, 2013 8:00 am | by The Associated Press | News | Comments

Quidel Corporation (NASDAQ: QDEL) and Life Technologies Corporation (NASDAQ: LIFE) announced today that they received 510(k) clearances from the United States Food and Drug Administration (FDA) to market the Quidel Molecular Direct C. difficile Assay with Life Technologies'...

Pathwork Diagnostics Collaborating with Kindstar Global to Provide Tissue of Origin Test in China

March 14, 2013 11:00 am | by The Associated Press | News | Comments

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Mar 14, 2013--Pathwork Diagnostics, Inc., the innovator of the Pathwork Tissue of Origin Test and a pioneer in creating genomics-based diagnostics in oncology, announced today that it has entered into an agreement with Kindstar Global (Kindstar) to provide...

Atossa Genetics Announces National Agreement With Network Provider FedMed

March 13, 2013 8:30 am | by The Associated Press | News | Comments

Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has entered into a contractual agreement with FedMed, Inc., one of the largest proprietary Preferred Provider Organization (PPO) networks in the U.S., for diagnostic laboratory testing. FedMed's network is...

NeuroMetrix Partners with Handok Pharmaceuticals for NC-stat DPNCheck Distribution in the Republic of Korea

March 12, 2013 7:00 am | by The Associated Press | News | Comments

WALTHAM, Mass.--(BUSINESS WIRE)--Mar 12, 2013--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that it has entered an agreement with Handok Pharmaceuticals, Inc. Under terms of the agreement,...


University of Texas Health Science Center at Houston Releases News of Successful NanoLogix Test

March 12, 2013 1:38 am | by The Associated Press | News | Comments

UTHealth researchers say more rapid test for Group B strep successful NanoLogix Inc. (OTC: NNLX), an innovator in the accelerated detection, identification and antibiotic sensitivity determination of live bacteria, announces that final results of a 14 month study done by researchers at UTHSC-Houston have been published in a recent online edition of “ Infectious Diseases in Obstetrics and Gynecology.”

Screening for BNP & Targeted Care Reduce Heart Failure in At-Risk Patients

March 11, 2013 5:52 pm | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Mar 11, 2013--Alere Inc. (NYSE: ALR) is pleased to announce the results of research presented at today’s American College of Cardiology’s 62nd Annual Scientific Session, which showed that a simple screening and management program can be effective in preventing heart...

Designers, Hackers, Healers, & Hustlers Tackle Employee Wellness in Innovation Challenge

March 11, 2013 4:50 pm | by Ryan Wynia, Founder|Design Visioneer, FIREBONE | Articles | Comments

The innovators selected to participate in StartX MedIC were unbelievable individuals. The participants included physicians, surgeons, physicists, electrical engineers, mechanical engineers, computer scientists, data scientists, computer programmers, industrial designers, interface designers, interaction designers, start-up founders, serial entrepreneurs, inventors, PhD students, medical students, and marketing executives from all types organizations and institutions.

Data Presented at ACC 2013 Confirms Use of Corus@ CAD in Women with Suspected Obstructive Coronary Artery Disease Influences Patient Management Decisions

March 11, 2013 8:31 am | by The Associated Press | News | Comments

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of a prospective study that evaluated how Corus@ CAD, a blood-based gene expression test, influenced cardiologists' patient management decisions in women with suspected obstructive coronary...

NovaSom is AASM’s First Approved Out of Center Sleep Test Provider

March 11, 2013 8:04 am | by The Associated Press | News | Comments

GLEN BURNIE, Md.--(BUSINESS WIRE)--Mar 11, 2013--NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announced it has been recognized by the American Academy of Sleep Medicine (AASM) as the first Approved Out of Center Sleep...


American Academy of Private Physicians (AAPP) Selects Itamar-Medical’s EndoPAT™ and WatchPAT™ Products to Promote Patient Wellness

March 11, 2013 8:00 am | by The Associated Press | News | Comments

CAESAREA, Israel--(BUSINESS WIRE)--Mar 11, 2013--Itamar-Medical (TASE: ITMR), the world's leader of noninvasive technology for diagnosis of cardiovascular health, announced today that it has an agreement with the American Academy of Private Physicians (AAPP) to include Itamar's EndoPAT &...

DNA Sequencing Giant Illumina Joins Hunt for Autism Blood Test

March 8, 2013 4:37 pm | by Massachusetts Institute of Technology | News | Comments

Illumina will work with SynapDx’s to find a blood-test that could allow treatment to start earlier. Massachusetts startup SynapDx announced on Wednesday that it will work with DNA sequencer manufacturer Illumina  to develop early detection tools for autism spectrum disorders, according to a release.

Endeavor Power Corporation Introduces Its Proprietary FDA Cleared Target System Platform Technology

March 8, 2013 8:00 am | by PR Newswire | News | Comments

CAMBRIDGE, Mass., March 8, 2013 /PRNewswire/ -- Endeavor Power Corporation ("Endeavor Power" or the "Company") (OTCQB: EDVP) introduces its proprietary FDA Cleared Target System Platform Immunoassay Testing Technology ("Target System"). Endeavor Sciences, Inc. ("Endeavor"), the...

Philips Healthcare and Infraredx Introduce Solution to Enable Seamless Integration of TVC Imaging System with Philips’ Allura Xper Systems

March 7, 2013 8:30 am | by The Associated Press | News | Comments

ANDOVER, Mass. & BURLINGTON, Mass.--(BUSINESS WIRE)--Mar 7, 2013--Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced the availability...

In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization

March 7, 2013 8:04 am | by PR Newswire | News | Comments

Global in vitro diagnostics markets are a bright spot in the healthcare industry largely due to the increasing focus on global expansion. This is particularly seen in emerging markets that continue to gain steam as markets flatten. This briefing, featuring a live Q&A with the industry analyst, will explore the IVD market dynamics in these and other key regions globally.

Clinical Trial Results for Dune Medical Devices' MarginProbe@ System Presented at 66th Annual SSO Cancer Symposium

March 7, 2013 8:01 am | by The Associated Press | News | Comments

Dune Medical Devices, Inc., announced today that results from the pivotal clinical trial for the MarginProbe System, Dune's breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, were presented at the 66th Annual Society of Surgical Oncology (SSO) Cancer ...

HD Medical, Inc. Launches US Business Operations

March 6, 2013 8:05 am | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Mar 6, 2013--At ACC.13, HD Medical Inc. a recently formed medical device research and development innovator headquartered in Santa Clara, CA, today announces the launch of US business operations. This new company is delivering revolutionary diagnostic technologies...

Appointment of Dr. Ian Gilham as Chairman of the Board

March 5, 2013 2:23 pm | by Bio-Medicine.Org | News | Comments

LISBON, Portugal , March 5, 2013 /- Biosurfit, a rapidly-growing company focused on the Point of Care medical diagnostic market, is pleased to announce today the appointment of Dr. Ian Gilham as Chairman of the Board. Previously, Dr. Ian Gilham was Chief Executive Officer of Axis-Shield plc, the in-vitro diagnostics company acquired by Alere in November 2011 for £...

AgPlus Diagnostics Unveils First Working Prototype of Handheld, Rapid, On-the-Spot Diagnostic System

March 5, 2013 12:01 pm | by AgPlus Diagnostics | News | Comments

AgPlus Diagnostics is pleased to announce that the first functional prototype of the handheld AgPlus Diagnostics analytical platform is now fully operational and available for demonstration. Delivering laboratory-grade, quantifiable results within just 10 minutes of sample application, the portable AgPlus technology system has enormous potential in a wide variety of applications.

Welch Allyn Will Showcase the EarlySense Contact-Free Patient Monitoring and Electronic Vitals Documentation Systems at HIMSS13

March 4, 2013 10:24 am | by Welch Allyn | News | Comments

Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, will showcase the EarlySense Vitals Surveillance System at the Healthcare Information and Management Systems Society (HIMSS) trade show this week at the Ernest N. Morial Convention Center in New Orleans.

FDA Clears Philips' MicroDose SI Mammography System

March 4, 2013 9:29 am | by Mass Device | News | Comments

Technology giant Philips won FDA clearance for its MicroDose SI full-field mammography system, which the company hopes to leverage as a platform new mammogram imaging applications. The system promises reduced radiation dosages in producing high quality images, 5-minute exam times and ergonomic design with curved and warmed breast support.

Larry Cohen Appointed CEO of Exalenz Bioscience

March 4, 2013 8:30 am | by The Associated Press | News | Comments

MODIIN, Israel--(BUSINESS WIRE)--Mar 4, 2013--Exalenz Bioscience (TASE: EXEN), a developer of a unique medical device intended for the diagnostics and management of disease of the digestive tract and the liver, has reported today the appointment of Larry Cohen as the company's CEO.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.